Q97722958

Summary

Q97722958 is an individual motion^[1].

Key Facts

• Q97722958 authored Said Abdu^[2].
• Q97722958 authored Barbro Westerholm^[3].
• Q97722958's instance of is recorded as individual motion^[4].
• Q97722958's part of the series is recorded as motions of 2017-2018 legislative session of the Riksdag^[5].
• Q97722958's language of work or name is recorded as Swedish^[6].
• Q97722958's publication date is recorded as +2017-09-28T00:00:00Z^[7].
• Q97722958's main subject is recorded as medication^[8].
• Q97722958's work available at URL is recorded as http://data.riksdagen.se/dokument/H502417^[9].
• Q97722958's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H502417^[10].
• Q97722958's applies to jurisdiction is recorded as Sweden^[11].
• Q97722958's legal citation of this text is recorded as Mot. 2017/18:417^[12].
• Q97722958's title is recorded as Reglering av nanoteknik vid framställning av läkemedel och medicintekniska produkter^[13].
• Q97722958's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97722958's copyright status is recorded as public domain^[15].
• Q97722958's legislative committee is recorded as Committee on Health and Welfare^[16].
• Q97722958's Swedish Riksdag document ID is recorded as H502417^[17].

Body

Works and Contributions

Authored works include Said Abdu^[2], a politician^[18], b. 1986^[19], of Sweden^[20] and Barbro Westerholm^[3], a politician^[21], 1933–2023^[22], of Sweden^[23], awarded the Ingemar Hedenius Prize^[24].